Cargando…
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clini...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610045/ https://www.ncbi.nlm.nih.gov/pubmed/26483189 http://dx.doi.org/10.1186/s12885-015-1732-9 |
_version_ | 1782395890989793280 |
---|---|
author | Habu, Noboru Imanishi, Yorihisa Kameyama, Kaori Shimoda, Masayuki Tokumaru, Yutaka Sakamoto, Koji Fujii, Ryoichi Shigetomi, Seiji Otsuka, Kuninori Sato, Yoichiro Watanabe, Yoshihiro Ozawa, Hiroyuki Tomita, Toshiki Fujii, Masato Ogawa, Kaoru |
author_facet | Habu, Noboru Imanishi, Yorihisa Kameyama, Kaori Shimoda, Masayuki Tokumaru, Yutaka Sakamoto, Koji Fujii, Ryoichi Shigetomi, Seiji Otsuka, Kuninori Sato, Yoichiro Watanabe, Yoshihiro Ozawa, Hiroyuki Tomita, Toshiki Fujii, Masato Ogawa, Kaoru |
author_sort | Habu, Noboru |
collection | PubMed |
description | BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clinical stage I/II (T1-2N0M0) tongue squamous cell carcinoma (TSCC) typically undergo partial glossectomy; however, development of delayed neck metastasis (DNM) tends to reduce their survival. In the present study, we aimed to determine the CSC markers in the SP of HNSCC cells along with their functions in cellular behaviors, and to clarify the association of these markers with DNM. METHODS: Flow cytometry was applied to isolate SP from main population (MP) in HNSCC cells. The expression of the CSC markers was examined by semi-quantitative RT-PCR and immunocytochemistry. In vitro proliferation, migration, and invasion assays were performed to assess cellular behaviors. Clinicopathological factors and immunohistochemical expressions of Oct3/4 and Nanog were evaluated using surgical specimens from 50 patients with stage I/II TSCC. RESULTS: SPs were isolated in all three cell lines examined. Expression levels of Oct3/4 and Nanog were higher in SP cells than MP cells. Additionally, cell migration and invasion abilities were higher in SP cells than MP cells, whereas there was no difference in proliferation. Univariate analysis showed that expression of Oct3/4 and Nanog, vascular and muscular invasion, and mode of invasion were significantly correlated with DNM. Multivariate logistic regression revealed that Oct3/4 expression (risk ratio = 14.78, p = 0.002) and vascular invasion (risk ratio = 12.93, p = 0.017) were independently predictive of DNM. Regarding the diagnostic performance, Oct3/4 showed the highest accuracy, sensitivity, and NPV of 82.0 %, 61.5 %, and 86.8 %, respectively, while vascular invasion showed the highest specificity and PPV of 94.6 % and 71.4 %, respectively. CONCLUSION: These results suggest that Oct3/4 and Nanog represent probable CSC markers in HNSCC, which contribute to the development of DNM in part by enhancing cell motility and invasiveness. Moreover, along with vascular invasion, expression of Oct3/4 can be considered a potential predictor for selecting patients at high risk of developing DNM. |
format | Online Article Text |
id | pubmed-4610045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46100452015-10-20 Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma Habu, Noboru Imanishi, Yorihisa Kameyama, Kaori Shimoda, Masayuki Tokumaru, Yutaka Sakamoto, Koji Fujii, Ryoichi Shigetomi, Seiji Otsuka, Kuninori Sato, Yoichiro Watanabe, Yoshihiro Ozawa, Hiroyuki Tomita, Toshiki Fujii, Masato Ogawa, Kaoru BMC Cancer Research Article BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clinical stage I/II (T1-2N0M0) tongue squamous cell carcinoma (TSCC) typically undergo partial glossectomy; however, development of delayed neck metastasis (DNM) tends to reduce their survival. In the present study, we aimed to determine the CSC markers in the SP of HNSCC cells along with their functions in cellular behaviors, and to clarify the association of these markers with DNM. METHODS: Flow cytometry was applied to isolate SP from main population (MP) in HNSCC cells. The expression of the CSC markers was examined by semi-quantitative RT-PCR and immunocytochemistry. In vitro proliferation, migration, and invasion assays were performed to assess cellular behaviors. Clinicopathological factors and immunohistochemical expressions of Oct3/4 and Nanog were evaluated using surgical specimens from 50 patients with stage I/II TSCC. RESULTS: SPs were isolated in all three cell lines examined. Expression levels of Oct3/4 and Nanog were higher in SP cells than MP cells. Additionally, cell migration and invasion abilities were higher in SP cells than MP cells, whereas there was no difference in proliferation. Univariate analysis showed that expression of Oct3/4 and Nanog, vascular and muscular invasion, and mode of invasion were significantly correlated with DNM. Multivariate logistic regression revealed that Oct3/4 expression (risk ratio = 14.78, p = 0.002) and vascular invasion (risk ratio = 12.93, p = 0.017) were independently predictive of DNM. Regarding the diagnostic performance, Oct3/4 showed the highest accuracy, sensitivity, and NPV of 82.0 %, 61.5 %, and 86.8 %, respectively, while vascular invasion showed the highest specificity and PPV of 94.6 % and 71.4 %, respectively. CONCLUSION: These results suggest that Oct3/4 and Nanog represent probable CSC markers in HNSCC, which contribute to the development of DNM in part by enhancing cell motility and invasiveness. Moreover, along with vascular invasion, expression of Oct3/4 can be considered a potential predictor for selecting patients at high risk of developing DNM. BioMed Central 2015-10-19 /pmc/articles/PMC4610045/ /pubmed/26483189 http://dx.doi.org/10.1186/s12885-015-1732-9 Text en © Habu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Habu, Noboru Imanishi, Yorihisa Kameyama, Kaori Shimoda, Masayuki Tokumaru, Yutaka Sakamoto, Koji Fujii, Ryoichi Shigetomi, Seiji Otsuka, Kuninori Sato, Yoichiro Watanabe, Yoshihiro Ozawa, Hiroyuki Tomita, Toshiki Fujii, Masato Ogawa, Kaoru Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title | Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title_full | Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title_fullStr | Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title_full_unstemmed | Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title_short | Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma |
title_sort | expression of oct3/4 and nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage i/ii oral tongue squamous cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610045/ https://www.ncbi.nlm.nih.gov/pubmed/26483189 http://dx.doi.org/10.1186/s12885-015-1732-9 |
work_keys_str_mv | AT habunoboru expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT imanishiyorihisa expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT kameyamakaori expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT shimodamasayuki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT tokumaruyutaka expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT sakamotokoji expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT fujiiryoichi expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT shigetomiseiji expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT otsukakuninori expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT satoyoichiro expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT watanabeyoshihiro expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT ozawahiroyuki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT tomitatoshiki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT fujiimasato expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma AT ogawakaoru expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma |